Brief report
Cardiac transplant waiting lists, donor shortage and retransplantation and implications for using donor hearts

https://doi.org/10.1016/0002-9149(91)90844-BGet rights and content

Abstract

Cardiac transplantation is established as the standard therapy for end-stage heart failure.1 The shortage of donors is the limiting factor in heart transplantation.2 Much emphasis has been placed on increasing donor referrals3 and appropriate management of potential donors to widen the donor pool.4 An alternative approach is to examine potential cardiac transplant recipients and identify patient subgroups with poor survival. We assessed the impact of donor shortage on the mortality of patients awaiting operation.

References (5)

There are more references available in the full text version of this article.

Cited by (17)

  • A potentially curative fetal intervention for hypoplastic left heart syndrome

    2018, Medical Hypotheses
    Citation Excerpt :

    However, due to limited availability of immunologically compatible, neonatal donor hearts, cardiac transplantation it is not routinely performed. Indeed, many infants die awaiting transplantation [16–20]. Moreover, even when a suitable donor heart is available, transplantation surgery in the neonate carries significant risk [21].

  • Cardiac retransplantation in children

    2004, Annals of Thoracic Surgery
    Citation Excerpt :

    Other individual centers have confirmed these poorer results with cardiac retransplantation in adults. Mullins and colleagues [6] from Papworth Hospital in Great Britain reported a 33% 1-year survival with 13 retransplants in 12 patients. The Utah transplant group had a 1-year survival rate of 74% in 20 retransplant patients compared with an 88% 1-year survival with primary transplantation [8].

View all citing articles on Scopus
View full text